Aging

As we age, our risk of developing many diseases such as Type II diabetes increases. Three-quarters of all cancers are diagnosed after the age of 55. An estimated 4.5 million Americans have Alzheimer's disease and about 60,000 new cases of Parkinson's disease are diagnosed each year, usually after the age of 65.
The Glenn Center for Aging Research will strengthen Salk's focus on understanding the cascade of events that accompany the aging process with the overarching goal to contribute scientific discoveries that can promote healthy aging for humanity.
The Glenn Center for Aging Research Will:
- Have great therapeutic value for age-associated diseases ranging from neuro-degenerative maladies to cancer, and positively impact the additional health costs associated with increased longevity.
- Lead to mechanistic insights into the aging process by exploiting comparative biology and human population studies.
- Help Salk scientists understand how altered metabolism influences aging and the mechanism that regulates the redistribution of fat, causing insulin resistance in older population.
Your Gifts Support:
- The recruitment and set-up packages for new faculty members who work in this area of research to round out the current expertise in mechanistic aging studies at the Institute.
- Renovation of existing laboratory space to accommodate new faculty members and their students.
- The research and training program that will help prepare the next generation of scientists in the area of mechanistic aging studies.
For information on how to contribute to this initiative, contact:
Rebecca Newman
Vice President, Development and Communications
858-453-4100 x1454
e-mail: rnewman@salk.edu.
